Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-050239)

Filing Details

Accession Number:: 0001209191-13-050239
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-01 19:03:25
Reporting Period:: 2013-10-30

Filing Date:: 2013-11-01
Accepted Time:: 2013-11-01 19:03:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1337553	Aerie Pharmaceuticals Inc	AERI	Biological Products, (No Disgnostic Substances) (2836)	203109565

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1207633	Jr Vicente Anido	C/O Aerie Pharmaceuticals, Inc. 135 U.s. Highway 206, Suite 15 Bedminster NJ 07921	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-10-30	28,000	$10.00	28,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These shares of Common Stock were purchased in connection with the issuer's initial public offering (the "IPO") at the IPO price pursuant to a registration statement on Form S-1 under the Securities Act of 1933, as amended, pursuant to a directed share program under which certain shares of Common Stock offered in the IPO were sold to the issuer's directors, officers, employees, consultants and other individuals associated with the issuer.